ArticleScientific reports2019

The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery.

Kotaro Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.